Czech Republic NEN contract award · ocds-ted-619679-2025
Czechia – Pharmaceutical products – Lutecium-177 oxodotreotid [2025]
Masarykův onkologický ústav awarded Kč74.2M to Novartis s.r.o. for Healthcare & Medical in September 2025 — one of 349 awards this buyer has made, above its typical award size.
23 Sep 2025
Award date
Kč74.2M
Contract value
Buying agency
Masarykův onkologický ústav 349 Awards
Kč16.9M Avg award
Above vs typical
Winning supplier
Novartis s.r.o. 15 Awards
7 Buyers
Kč2.0B Total won
Contract description
Czechia – Pharmaceutical products – Lutecium-177 oxodotreotid [2025]
Premium
Related awards · Masarykův onkologický ústav
349 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
Tender no.SupplierAmountDateSector
- ocds-ted-359550-2026LERAM diagnostic s.r.o.Kč252M27 May 2026 Healthcare
- ocds-ted-255026-2025SYNEKTIK Czech Republic, s.r.o.Kč246M18 Apr 2025 Healthcare
- ocds-ted-479599-2026-2Bristol-Myers Squibb spol. s r.o.Kč150M10 Jul 2026 Healthcare
Premium
Other wins · Novartis s.r.o.
15 winsThe supplier's complete win history across every buyer it sells to — not just the handful shown here.
Tender no.BuyerAmountDateSector
- ocds-ted-695488-2025Fakultní nemocnice v MotoleKč1.4B22 Oct 2025 Healthcare
- ocds-ted-622376-2025Masarykův onkologický ústavKč124M23 Sep 2025 Healthcare
- ocds-ted-351155-2025Nemocnice Na HomolceKč103M02 Jun 2025 Healthcare
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for Masarykův onkologický ústav and Novartis s.r.o. — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back